MEDIGUS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.62 USD | +5.22% |
|
+4.80% | -19.63% |
| Apr. 18 | Medigus Ltd. will Change its Ticker to XYLO from MDGS | CI |
| Apr. 18 | Medigus Ltd. will Change its Name to Xylo Technologies Ltd | CI |
Financials (USD)
| Sales 2021 | 10.12M | Sales 2022 | 91.86M | Capitalization | 7.66M |
|---|---|---|---|---|---|
| Net income 2021 | 6M | Net income 2022 | -9M | EV / Sales 2021 | -0.19 x |
| Net cash position 2021 | 25.72M | Net cash position 2022 | 14.92M | EV / Sales 2022 | -0.08 x |
| P/E ratio 2021 |
5
x | P/E ratio 2022 |
-0.77
x | Employees | 77 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +5.22% | ||
| 1 week | +4.80% | ||
| Current month | -4.38% | ||
| 1 month | -3.68% | ||
| 3 months | -22.94% | ||
| 6 months | -21.07% | ||
| Current year | -19.63% |
1 week
2.11
2.95
1 month
2.112.95
Current year
2.113.66
1 year
2.117.17
3 years
2.1136.75
5 years
2.1177.25
10 years
2.113 102.00
| Managers | Title | Age | Since |
|---|---|---|---|
Liron Carmel
CEO | Chief Executive Officer | 39 | 19-03-31 |
Tali Dinar
DFI | Director of Finance/CFO | 51 | 21-06-07 |
| Chief Tech/Sci/R&D Officer | 73 | 99-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Eliyahu Yoresh
CHM | Chairman | 54 | 18-08-31 |
Eli Cohen
BRD | Director/Board Member | 55 | 18-09-19 |
Ronen Rosenbloom
BRD | Director/Board Member | 52 | 18-09-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 2.62 | +5.22% | 19 571 |
| 24-04-18 | 2.45 | +3.81% | 18,586 |
| 24-04-17 | 2.36 | +8.28% | 28,869 |
| 24-04-16 | 2.18 | -2.26% | 10,505 |
| 24-04-15 | 2.23 | -10.80% | 61,386 |
Delayed Quote Nasdaq, April 19, 2024 at 04:30 pm EDT
More quotes
Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
Calendar
2024-04-30
- Q4 2023 Earnings Release (Projected)
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.63% | 4.64M | |
| +2.64% | 207B | |
| +1.80% | 175B | |
| +8.59% | 132B | |
| +16.47% | 99.1B | |
| -3.42% | 60.89B | |
| +12.71% | 52.04B | |
| -6.61% | 45.48B | |
| -4.53% | 38.81B | |
| +9.27% | 38.77B |
- Stock Market
- Equities
- MDGS Stock
